<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01917682</url>
  </required_header>
  <id_info>
    <org_study_id>PRECISION CorPath Registry</org_study_id>
    <nct_id>NCT01917682</nct_id>
  </id_info>
  <brief_title>Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions</brief_title>
  <acronym>PRECISION</acronym>
  <official_title>A Post-Market Registry for the Evaluation of the CorPath 200 System Effectiveness in Percutaneous Coronary Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corindus Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corindus Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To collect data on the routine patterns of use, safety and effectiveness, including the&#xD;
      clinical and technical performance of the CorPath 200 System, in the delivery and&#xD;
      manipulation of coronary guidewires and stent/balloon catheters during PCI procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, single-arm, open-label, multi-center patient registry of the CorPath&#xD;
      200 System to examine its performance during PCI procedure and patient outcomes through 72&#xD;
      hours post-procedure or hospital discharge, whichever occurs first.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>3 Days</target_duration>
  <primary_outcome>
    <measure>Number of Participants With Clinical Success</measure>
    <time_frame>In-hospital (72-hours or discharge, whichever occurs first)</time_frame>
    <description>Less than 30% residual stenosis post PCI in the lesion(s) treated with the CorPath system, without in-hospital major adverse coronary events (MACE).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With In-hospital Major Adverse Coronary Events (MACE)</measure>
    <time_frame>In-hospital (72-hours or discharge, whichever occurs first)</time_frame>
    <description>The composite of death, myocardial infarction, and target vessel revascularization that occurs within 72 hours of the procedure or prior to hospital discharge, whichever occurs first, in a subject treated with the CorPath 200 System.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With an Adverse Event</measure>
    <time_frame>In-hospital (72-hours or discharge, whichever occurs first)</time_frame>
    <description>All Serious Adverse Events (SAEs) and Unanticipated Adverse Device Effects (UADEs) from the start of the CorPath procedure until the end of the study will be summarized.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Overall Procedure Time</measure>
    <time_frame>During procedure</time_frame>
    <description>Defined as the time measured from the insertion of the hemostasis sheath until the removal of the guide catheter.</description>
  </other_outcome>
  <other_outcome>
    <measure>PCI Procedure Time</measure>
    <time_frame>During procedure</time_frame>
    <description>Defined as the time measured from the insertion of the guide catheter until the removal of the guide catheter.</description>
  </other_outcome>
  <other_outcome>
    <measure>Fluoroscopy and/or X-Ray Time</measure>
    <time_frame>During procedure</time_frame>
    <description>As recorded by an X-Ray System utilized during the procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Contrast Fluid Volume</measure>
    <time_frame>During procedure</time_frame>
    <description>The amount of contrast fluid used (mL) during the procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Radiation Exposure - Dose-Area-Product</measure>
    <time_frame>During procedure</time_frame>
    <description>DAP (dose-area-product) as recorded during the procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Radiation Exposure - Cumulative Dose</measure>
    <time_frame>During procedure</time_frame>
    <description>Cumulative dose (mGy) as recored during the procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants Who Had a Conversions to Manual Technique.</measure>
    <time_frame>During procedure</time_frame>
    <description>The overall number of conversions from the robotic PCI to manual PCI will be captured to analyze the technical success of the device.</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Measurement of Lesion Length</measure>
    <time_frame>During procedure</time_frame>
    <description>Visual estimate by clinical operator prior to delivery of PCI device(s).</description>
  </other_outcome>
  <other_outcome>
    <measure>CorPath Measurement of Lesion Length</measure>
    <time_frame>During procedure</time_frame>
    <description>Robotic measurement of lesion length using the CorPath System performed by the Clinical Operator.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">754</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Coronary Disease</condition>
  <condition>Myocardial Ischemia</condition>
  <condition>Heart Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Arteriosclerosis</condition>
  <condition>Arterial Occlusive Diseases</condition>
  <condition>Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>Study Cohort</arm_group_label>
    <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CorPath-assisted Percutaneous Coronary Intervention</intervention_name>
    <description>Robotic-assisted Percutaneous Coronary Intervention</description>
    <arm_group_label>Study Cohort</arm_group_label>
    <other_name>Robotic-assisted Percutaneous Coronary Intervention</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with coronary artery disease and with the clinical indication for Percutaneous&#xD;
        Coronary Intervention (PCI).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt;18 years.&#xD;
&#xD;
          2. Patients with coronary artery disease undergoing Percutaneous Coronary Intervention&#xD;
             (PCI) with the CorPath 200 system.&#xD;
&#xD;
          3. The subject or the legal representative has been informed of the nature of the study,&#xD;
             agrees to its provisions and has provided written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Concurrent enrollment in another device or drug study protocol that specifically&#xD;
             excludes concurrent enrollment or that prevents collection of data required in this&#xD;
             registry (concurrent participation in another registry is not an automatic exclusion&#xD;
             criterion for this study).&#xD;
&#xD;
          2. Failure/inability/unwillingness to provide informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giora Weisz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University Medical Center/New York-Presbyterian Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chris Cain</last_name>
    <role>Study Director</role>
    <affiliation>VP, Clinical Affairs</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UC San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley View Hospital</name>
      <address>
        <city>Glenwood Springs</city>
        <state>Colorado</state>
        <zip>81601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medstar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orlando Regional Medical Center</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Georgia Heart Foundation</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth's Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health System</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center/New York-Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital Health Center</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center - Northeast</name>
      <address>
        <city>Concord</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford Health</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth Univ. Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.corindus.com</url>
    <description>Visit the Corindus website for related information.</description>
  </link>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>August 2, 2013</study_first_submitted>
  <study_first_submitted_qc>August 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2013</study_first_posted>
  <results_first_submitted>November 5, 2020</results_first_submitted>
  <results_first_submitted_qc>November 30, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 2, 2020</results_first_posted>
  <last_update_submitted>December 1, 2020</last_update_submitted>
  <last_update_submitted_qc>December 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>robotic-assisted PCI</keyword>
  <keyword>coronary intervention</keyword>
  <keyword>CorPath PRECISION Registry</keyword>
  <keyword>PCI</keyword>
  <keyword>angioplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients that had a robotic-assisted PCI procedure.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Study Cohort</title>
          <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="754"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="754"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Study Cohort</title>
          <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="754"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.9" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="200"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="554"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Clinical Success</title>
        <description>Less than 30% residual stenosis post PCI in the lesion(s) treated with the CorPath system, without in-hospital major adverse coronary events (MACE).</description>
        <time_frame>In-hospital (72-hours or discharge, whichever occurs first)</time_frame>
        <population>Number of participants with complete data to assess clinical success.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinical Success</title>
          <description>Less than 30% residual stenosis post PCI in the lesion(s) treated with the CorPath system, without in-hospital major adverse coronary events (MACE).</description>
          <population>Number of participants with complete data to assess clinical success.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="743"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With In-hospital Major Adverse Coronary Events (MACE)</title>
        <description>The composite of death, myocardial infarction, and target vessel revascularization that occurs within 72 hours of the procedure or prior to hospital discharge, whichever occurs first, in a subject treated with the CorPath 200 System.</description>
        <time_frame>In-hospital (72-hours or discharge, whichever occurs first)</time_frame>
        <population>Number of participants with complete data to assess In-hospital Major Adverse Coronary Events (MACE).</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With In-hospital Major Adverse Coronary Events (MACE)</title>
          <description>The composite of death, myocardial infarction, and target vessel revascularization that occurs within 72 hours of the procedure or prior to hospital discharge, whichever occurs first, in a subject treated with the CorPath 200 System.</description>
          <population>Number of participants with complete data to assess In-hospital Major Adverse Coronary Events (MACE).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="754"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With an Adverse Event</title>
        <description>All Serious Adverse Events (SAEs) and Unanticipated Adverse Device Effects (UADEs) from the start of the CorPath procedure until the end of the study will be summarized.</description>
        <time_frame>In-hospital (72-hours or discharge, whichever occurs first)</time_frame>
        <population>Number of participants with complete data to assess Adverse Events.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With an Adverse Event</title>
          <description>All Serious Adverse Events (SAEs) and Unanticipated Adverse Device Effects (UADEs) from the start of the CorPath procedure until the end of the study will be summarized.</description>
          <population>Number of participants with complete data to assess Adverse Events.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="754"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Overall Procedure Time</title>
        <description>Defined as the time measured from the insertion of the hemostasis sheath until the removal of the guide catheter.</description>
        <time_frame>During procedure</time_frame>
        <population>Number of participants that had completed data to assess Overall procedure time.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Procedure Time</title>
          <description>Defined as the time measured from the insertion of the hemostasis sheath until the removal of the guide catheter.</description>
          <population>Number of participants that had completed data to assess Overall procedure time.</population>
          <units>min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="722"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.9" spread="28.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>PCI Procedure Time</title>
        <description>Defined as the time measured from the insertion of the guide catheter until the removal of the guide catheter.</description>
        <time_frame>During procedure</time_frame>
        <population>Number of participants that had complete data to assess PCI procedure time.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>PCI Procedure Time</title>
          <description>Defined as the time measured from the insertion of the guide catheter until the removal of the guide catheter.</description>
          <population>Number of participants that had complete data to assess PCI procedure time.</population>
          <units>min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="696"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.6" spread="23.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Fluoroscopy and/or X-Ray Time</title>
        <description>As recorded by an X-Ray System utilized during the procedure.</description>
        <time_frame>During procedure</time_frame>
        <population>Number of participants with complete data to assess fluoroscopy and/or X-Ray time.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Fluoroscopy and/or X-Ray Time</title>
          <description>As recorded by an X-Ray System utilized during the procedure.</description>
          <population>Number of participants with complete data to assess fluoroscopy and/or X-Ray time.</population>
          <units>min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="753"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Contrast Fluid Volume</title>
        <description>The amount of contrast fluid used (mL) during the procedure.</description>
        <time_frame>During procedure</time_frame>
        <population>Number of partcipants with completed data to assess contrast fluid volume.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Contrast Fluid Volume</title>
          <description>The amount of contrast fluid used (mL) during the procedure.</description>
          <population>Number of partcipants with completed data to assess contrast fluid volume.</population>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="750"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="181.1" spread="90.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Patient Radiation Exposure - Dose-Area-Product</title>
        <description>DAP (dose-area-product) as recorded during the procedure.</description>
        <time_frame>During procedure</time_frame>
        <population>Number of participants that had completed data to assess patient radiation exposure. The overall number of participants analyzed in the DAP and Cumulative groups differ because of incomplete data recorded from the sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Radiation Exposure - Dose-Area-Product</title>
          <description>DAP (dose-area-product) as recorded during the procedure.</description>
          <population>Number of participants that had completed data to assess patient radiation exposure. The overall number of participants analyzed in the DAP and Cumulative groups differ because of incomplete data recorded from the sites.</population>
          <units>mGy*cm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="635"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120861.3" spread="256522.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Patient Radiation Exposure - Cumulative Dose</title>
        <description>Cumulative dose (mGy) as recored during the procedure.</description>
        <time_frame>During procedure</time_frame>
        <population>Number of participants that had completed data to assess patient radiation exposure. The overall number of participants analyzed in the DAP and Cumulative groups differ because of incomplete data recorded from the sites.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Radiation Exposure - Cumulative Dose</title>
          <description>Cumulative dose (mGy) as recored during the procedure.</description>
          <population>Number of participants that had completed data to assess patient radiation exposure. The overall number of participants analyzed in the DAP and Cumulative groups differ because of incomplete data recorded from the sites.</population>
          <units>mGy</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="679"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1631.5" spread="3664.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Who Had a Conversions to Manual Technique.</title>
        <description>The overall number of conversions from the robotic PCI to manual PCI will be captured to analyze the technical success of the device.</description>
        <time_frame>During procedure</time_frame>
        <population>Number of conversions from the robotic PCI to manual PCI in participants with complete data.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had a Conversions to Manual Technique.</title>
          <description>The overall number of conversions from the robotic PCI to manual PCI will be captured to analyze the technical success of the device.</description>
          <population>Number of conversions from the robotic PCI to manual PCI in participants with complete data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="948"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Visual Measurement of Lesion Length</title>
        <description>Visual estimate by clinical operator prior to delivery of PCI device(s).</description>
        <time_frame>During procedure</time_frame>
        <population>Operator visual lesion length estimate.</population>
        <group_list>
          <group group_id="O1">
            <title>Visual Estimate</title>
            <description>Operator visual estimate of lesion length.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Measurement of Lesion Length</title>
          <description>Visual estimate by clinical operator prior to delivery of PCI device(s).</description>
          <population>Operator visual lesion length estimate.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Lesions</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="754"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Lesions</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="557"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.3" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>CorPath Measurement of Lesion Length</title>
        <description>Robotic measurement of lesion length using the CorPath System performed by the Clinical Operator.</description>
        <time_frame>During procedure</time_frame>
        <population>Lesion length measured with CorPath System.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Cohort</title>
            <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
          </group>
        </group_list>
        <measure>
          <title>CorPath Measurement of Lesion Length</title>
          <description>Robotic measurement of lesion length using the CorPath System performed by the Clinical Operator.</description>
          <population>Lesion length measured with CorPath System.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>lesions</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="754"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>lesions</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="557"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.1" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were assessed from the index procedure though participant discharged from the hospital or 72-hours post procedure, whichever occurred first.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Study Cohort</title>
          <description>Subjects treated with CorPath-assisted Percutaneous Coronary Intervention (PCI)&#xD;
CorPath-assisted Percutaneous Coronary Intervention: Robotic-assisted Percutaneous Coronary Intervention</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="754"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>TRANSIENT BRADYCARDIA/HYPOTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>FLUID RETENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>RECURRENT CHEST, RIGHT SHOULDER, RIGHT ARM PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>DISSECTION DURING MANUAL PCI LESION #2</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>LEFT MAIN DISSECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>ABRUPT VESSEL CLOSURE, DUE TO ANGIOPLASTY DISSECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>PERI-PROCEDURAL MI; NSTEMI/NON QWAVE MI</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>PEA ARREST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>CONTRAST DYE ALLERGIC REACTION; HYPOTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE NAUSEA AND VOMITING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE CEREBROVASCULAR ACCIDENT (CVA)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
              <event>
                <sub_title>HEMATOCHEZIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>RESPIRATORY DISTRESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="754"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="754"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John Van Vleet, VP of Clinical and Regulatory Affairs</name_or_title>
      <organization>Corindus, Inc.</organization>
      <phone>(260)615-8892</phone>
      <email>john.van_vleet@siemens-healthineers.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

